Dr. Zibelman on Combinations of Immunotherapy for RCCOncLiveThe combinations with immunotherapy and the oral TKIs are very promising and may be better tolerated. As time goes on, it will be between those combinations and attempting to identify which gr… Continue reading
Immunotherapy biotech Apellis Pharmaceuticals sets terms for $150 million IPONasdaqApellis Pharmaceuticals, which is developing a novel protein inhibitor for autoimmune and inflammatory diseases, announced terms for its IPO on Monday. The Crestwood, … Continue reading
|
Gene Therapy Hope
GenomeWeb Gene therapies have been getting a lot of notice lately, leading CNBC to ask a biotech investor what all the fuss is about. Novartis’ CAR-T cell therapy, Kymriah, became the first approved gene therapy in the US in August. The US Food and Drug … |